Propofol Injection, Emulsion
Product Images NDC 51662-1471

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 51662-1471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse Reactions 1 (Adverse Reactions 1)

A data table listing adverse reactions associated with PROPOFOL injection, emulsion 10 mg/mL. The table compares side effects seen in Anesthesia/MAC Sedation and ICU Sedation, categorized by systems such as cardiovascular, central nervous system, injection site, metabolic/nutritional, respiratory, and skin and appendages. It includes specific reactions like bradycardia, arrhythmia, hypotension, apnea, rash, and hyperlipemia with some pediatric incidence percentages.*

FDA Label Image

Adverse Reactions 2 (Adverse Reactions 2)

A data table listing adverse reactions organized by body system for a drug. It compares reported reactions under columns labeled "Anesthesia/MAC Sedation" and "ICU Sedation," including terms such as anaphylaxis, tachycardia, phlebitis, dizziness, wheezing, and urine color changes.*

FDA Label Image

Adverse Reactions 3 (Adverse Reactions 3)

A two-column table listing adverse reactions for PROPOFOL Injection, Emulsion 10 mg/mL. The columns compare side effects related to Anesthesia/MAC Sedation and ICU Sedation across body systems such as cardiovascular, central nervous system, digestive, metabolic, respiratory, and others.*

FDA Label Image

Image (Clinical P Image)

A line graph showing plasma propofol concentration (mg/mL) over time (minutes) after the end of infusion. It compares recovery trajectories following 1 hour, 10 hour, and 10 day infusions, with annotations marking target plasma concentration and awakening time points.*

FDA Label Image

Clinical P Tabels (Clinical P Tables)

Two tables presenting pediatric anesthesia dosing information for PROPOFOL. Table 1 details induction dose median and range, plus injection duration median and range, for ages birth through 16 years. Table 2 shows maintenance dosage and duration ranges for three pediatric age groups: 2 months-2 years, 2-12 years, and over 12 through 16 years.*

FDA Label Image

Dosage 1 (Dosage 1)

A dosage table for Propofol Injectable Emulsion showing primary agent rates for preinduction anxiolysis, induction, and maintenance phases, with accompanying secondary agent rates involving opioids. The table details specific infusion rates in mcg/kg/min and mg/kg for intravenous administration, highlighting titration to clinical response.*

FDA Label Image

Dosage 2 (Dosage 2)

This text panel provides detailed dosing and administration guidelines for propofol injection emulsion 10 mg/mL, covering indications for general anesthesia and sedation across various patient groups including healthy adults, elderly, pediatric, and critically ill patients. It specifies dosage ranges, administration routes, titration instructions, and notes on maintenance of anesthesia and sedation, with references to clinical pharmacology and prescribing information for adjustments based on age and health conditions.*

FDA Label Image

How Supplied (How Supplied)

A data table presenting units of sale and concentrations for Propofol injection in 10 mg/mL strength. It lists three packaging options: a carton of 5 fliptop vials (200 mg/20 mL), a tray of 20 fliptop vials (500 mg/50 mL), and a tray of 10 fliptop vials (1000 mg/100 mL). Each entry includes the corresponding NDC codes.*

FDA Label Image

Indications & Usage (Indications And Usage)

A table presenting approved patient populations for various indications of PROPOFOL injection, emulsion 10 mg/mL. Indications include initiation and maintenance of monitored anesthesia care sedation, combined sedation and regional anesthesia, induction and maintenance of general anesthesia, and intensive care unit sedation of intubated, mechanically ventilated patients. The table specifies age and patient criteria for each indication.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Labeling (Serialized Labeling)

Close-up image of a vial of PROPOFOL Injectable Emulsion 500 mg/50 mL (10 mg/mL) by HF Acquisition Co LLC. The vial contains a milky white emulsion with a blue cap. Label information visible includes intravenous administration, presence of benzyl alcohol, and instructions to shake well before use.*

FDA Label Image

Structure (Structure)

Chemical structure of propofol showing a phenol ring with two isopropyl groups and a hydroxyl group attached.*

FDA Label Image

Vial Label Opt. 1 (Vial Label Opt 1)

Label for PROPOFOL Injectable Emulsion 500 mg/50 mL (10 mg/mL) for intravenous administration. The label notes it contains benzyl alcohol and instructs to shake well before use. It is intended for single patient use only. The manufacturer is Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Vial Label Opt. 2 (Vial Label Opt 2)

Label for PROPOFOL Injectable Emulsion 500 mg/50 mL (10 mg/mL) for intravenous use. The label indicates the presence of benzyl alcohol and instructs to shake well before using. It is for single patient use only and manufactured for Hospira, Inc., Lake Forest, IL. The label includes storage instructions and a barcode, with a note that the product is sterile and nonpyrogenic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.